Latest News and Press Releases
Want to stay updated on the latest news?
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, May 31, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
NESS-ZIONA, Israel, March 11, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
-
Not for distribution by US newswire or in United States NESS-ZIONA, ISRAEL, Feb. 17, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
FURTHER UPDATE ON USAMRIID CHALLENGE AND ADDITIONAL EUROPEAN PATENT GRANTED FOR VAXIL’S ANTICANCER ANTIBODY PLATFORM Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. ...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
-
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 31, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...